Emerging evidences show that host inflammatory responses are associated with tumor
progression. NLR, which is calculated as the ratio of neutrophils to lymphocyte count, is …

The prognostic role of inflammation index like neutrophil‐to‐lymphocyte ratio (NLR) in
colorectal cancer (CRC) remains controversial. We conduct a meta‐analysis to determine …

Background Inflammatory responses play decisive roles in tumor development, immune
surveillance, and responses to therapy. High neutrophil-to-lymphocyte ratio (NLR), as an …

Background The incidence of colorectal cancer (CRC) is expected to increase by 80% in
year 2035. Even though advantages in treatment of CRC have being made over the last …

The neutrophil-to-lymphocyte ratio (NLR) is a prognostic inflammatory marker in colorectal
cancer (CRC), however, little is known for its prognostic role in stage II to III CRC patients …

Background Inflammation is a hallmark of cancer, and systemic markers of inflammation are
increasingly recognised as negative prognostic factors for clinical outcome. Neutrophil‐to …

The neutrophil‑to‑lymphocyte ratio (NLR) has been reported to be an independent
prognostic factor of unresectable advanced or metastatic colorectal cancer (uCRC) …

BACKGROUND AND OBJECTIVES The detection of a simple and reliable prognostic
biomarker for colorectal cancer (CRC) outcomes remains a significant challenge. The use of …

Aims: There is a growing body of evidence showing the functional relationship between
inflammation index like netrophil-lymphocyte ratio.(NLR) and colorectal cancer.(CRC) in …

AIM To evaluate the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and
platelet-to-lymphocyte ratio (PLR) in patients with colorectal cancer (CRC). METHODS …